GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA

NCT04108468 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Methotrexate
DRUG: Golimumab

Sponsor

The Leeds Teaching Hospitals NHS Trust

Collaborators

[object Object]